Hydatid disease (Hydatid cyst).
Conditions
Interventions
Intervention 1: Intervention group: 15 patients consumed orally the 20 mg soft capsules of Zataria multiflora essential oil (produced by Barij Essence Pharmaceutical Company, Iran) 3 times a day for 6
Sponsors
Shiraz University
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients who accepted the treatment protocol by signing the appropriate informed consent, Patients with hepatic hydatid cysts smaller than 5 cm, Patients with uncomplicated hydatid cysts (non calcified and non infected to bacterial infections), Patients who were not simultaneously infected to pulmonary hydatid disease
Exclusion criteria
Exclusion criteria: Refusal of treatment at each stage of the treatment period Patients with symptoms of complicated cysts (infection, abscessation). Enlargement of the cysts during the course of treatment. Adverse drug reactions leading to discontinuation of the treatment Patients who don’t refer for periodic examinations and necessary tests Recurrence of the disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the size of hydatid cysts. Timepoint: Before the start of treatment and after all treatment periods (totally 4 times). Method of measurement: By sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Moazeni
Shiraz University
Outcome results
None listed